Filing Details

Accession Number:
0001209191-11-029613
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-05-19 12:33:55
Reporting Period:
2011-05-18
Filing Date:
2011-05-19
Accepted Time:
2011-05-19 12:33:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1138400 Biomimetic Therapeutics Inc. BMTI Surgical & Medical Instruments & Apparatus (3841) 621786244
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1362148 Eugene Samuel Lynch Biomimetic Therapeutics, Inc.
389 Nichol Mill Lane
Franklin TN 37067
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-05-18 10,000 $7.90 895,912 No 4 P Direct
Common Stock Acquisiton 2011-05-18 3,000 $7.75 898,912 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 254,341 Indirect By Trust
Common Stock 5,100 Indirect By Wife
Footnotes
  1. The balance of common stock beneficially owned includes shares acquired by the Reporting Person since the previous Form 4 filing (on 1/21/2011), consisting of 1,898 shares purchased through the Issuer's Employee Stock Purchase Plan for the 1st quarter 2011.
  2. Shares are held in an irrevocable trust fund, of which Samuel E. Lynch is trustee.
  3. Dr. Lynch disclaims beneficial ownership of these shares except to the extent of his pecuniary interest in them.